Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy
The paper reviews an update on the possibilities of providing care for patients with spontaneous non-traumatic intracranial hemorrhage (ICH) developing in patients with atrial fibrillation who use oral anticoagulants. The incidence of ICH is shown to be considerably lower when nonvitamin K-dependent...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2019-06-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1138 |
| _version_ | 1827062781774397440 |
|---|---|
| author | S. N. Yanishevsky |
| author_facet | S. N. Yanishevsky |
| author_sort | S. N. Yanishevsky |
| collection | DOAJ |
| description | The paper reviews an update on the possibilities of providing care for patients with spontaneous non-traumatic intracranial hemorrhage (ICH) developing in patients with atrial fibrillation who use oral anticoagulants. The incidence of ICH is shown to be considerably lower when nonvitamin K-dependent anticoagulants (NOACs) are used, but the hematoma evolution scenarios do not differ between the groups of patients receiving vitamin K antagonists or NOACs. The results of studies assessing hypertension therapy in patients with ICH are compared. The possibilities of using various reversal agents for various oral anticoagulants are also discussed. Since one of the main problems associated with increased mortality and severe disabilities is the progression rate of ICH, the possibility of using a specific antagonist can determine the choice of an anticoagulant for the primary prevention of ischemic stroke in a patient with atrial fibrillation. |
| first_indexed | 2024-04-10T02:01:57Z |
| format | Article |
| id | doaj.art-62685ae12aa64e83b45b050dcda5c5fc |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2025-02-18T20:02:19Z |
| publishDate | 2019-06-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-62685ae12aa64e83b45b050dcda5c5fc2024-10-17T16:15:26ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422019-06-01113S828810.14412/2074-2711-2019-3S-82-88881Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapyS. N. Yanishevsky0S.M. Kirov Military Medical AcademyThe paper reviews an update on the possibilities of providing care for patients with spontaneous non-traumatic intracranial hemorrhage (ICH) developing in patients with atrial fibrillation who use oral anticoagulants. The incidence of ICH is shown to be considerably lower when nonvitamin K-dependent anticoagulants (NOACs) are used, but the hematoma evolution scenarios do not differ between the groups of patients receiving vitamin K antagonists or NOACs. The results of studies assessing hypertension therapy in patients with ICH are compared. The possibilities of using various reversal agents for various oral anticoagulants are also discussed. Since one of the main problems associated with increased mortality and severe disabilities is the progression rate of ICH, the possibility of using a specific antagonist can determine the choice of an anticoagulant for the primary prevention of ischemic stroke in a patient with atrial fibrillation.https://nnp.ima-press.net/nnp/article/view/1138atrial fibrillationstroke preventionintracranial hemorrhageoral anticoagulantsnew oral anticoagulantsdirect oral anticoagulantsvitamin k antagonistsspecific antagonistdabigatranidarucizumab |
| spellingShingle | S. N. Yanishevsky Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy Неврология, нейропсихиатрия, психосоматика atrial fibrillation stroke prevention intracranial hemorrhage oral anticoagulants new oral anticoagulants direct oral anticoagulants vitamin k antagonists specific antagonist dabigatran idarucizumab |
| title | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy |
| title_full | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy |
| title_fullStr | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy |
| title_full_unstemmed | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy |
| title_short | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy |
| title_sort | intracranial hemorrhage in patients taking oral anticoagulants current possibilities for therapy |
| topic | atrial fibrillation stroke prevention intracranial hemorrhage oral anticoagulants new oral anticoagulants direct oral anticoagulants vitamin k antagonists specific antagonist dabigatran idarucizumab |
| url | https://nnp.ima-press.net/nnp/article/view/1138 |
| work_keys_str_mv | AT snyanishevsky intracranialhemorrhageinpatientstakingoralanticoagulantscurrentpossibilitiesfortherapy |